Interleukin-38 promoter variants and risk of COVID-19 among Iraqis

Ahmed, 2022, Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients, Meta Gene, 31, 10.1016/j.mgene.2021.100989 Ahmed, 2021, Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19), Cytokine, 148, 10.1016/j.cyto.2021.155702 Al-bassam, 2022, Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019, J. Med. Virol., 10.1002/jmv.27762 Baillie, 2014, Targeting the host immune response to fight infection, Science (80-.), 344, 807, 10.1126/science.1255074 Baillie, 2013, Influenza — Time to Target the Host?, N. Engl. J. Med., 369, 191, 10.1056/NEJMcibr1304414 Barmania, 2022, Coronavirus Host Genetics South Africa (COHG-SA) database—a variant database for gene regions associated with SARS-CoV-2 outcomes, Eur. J. Hum. Genet., 1–9 Chamnanphon, 2022, Host genetic factors of COVID-19 susceptibility and disease severity in a Thai population, J. Hum. Genet., 67, 295, 10.1038/s10038-021-01009-6 Costela-Ruiz, 2020, SARS-CoV-2 infection: The role of cytokines in COVID-19 disease, Cytokine Growth Factor Rev., 54, 62, 10.1016/j.cytogfr.2020.06.001 de Graaf, 2021, IL-38 prevents induction of trained immunity by inhibition of mTOR signaling, J. Leukoc. Biol., 110, 907, 10.1002/JLB.3A0220-143RRR Dehghan, A., Dupuis, J., Barbalic, M., Bis, J.C., Eiriksdottir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., Baumert, J., Strachan, D.P., Fuchsberger, C., Vitart, V., Wilson, J.F., Paré, G., Naitza, S., Rudock, M.E., Surakka, I., De Geus, E.J.C., Alizadeh, B.Z., Guralnik, J., Shuldiner, A., Tanaka, T., Zee, R.Y.L., Schnabel, R.B., Nambi, V., Kavousi, M., Ripatti, S., Nauck, M., Smith, N.L., Smith, A. V., Sundvall, J., Scheet, P., Liu, Y., Ruokonen, A., Rose, L.M., Larson, M.G., Hoogeveen, R.C., Freimer, N.B., Teumer, A., Tracy, R.P., Launer, L.J., Buring, J.E., Yamamoto, J.F., Folsom, A.R., Sijbrands, E.J.G., Pankow, J., Elliott, P., Keaney, J.F., Sun, W., Sarin, A.P., Fontes, J.D., Badola, S., Astor, B.C., Hofman, A., Pouta, A., Werdan, K., Greiser, K.H., Kuss, O., Meyer Zu Schwabedissen, H.E., Thiery, J., Jamshidi, Y., Nolte, I.M., Soranzo, N., Spector, T.D., Völzke, H., Parker, A.N., Aspelund, T., Bates, D., Young, L., Tsui, K., Siscovick, D.S., Guo, X., Rotter, J.I., Uda, M., Schlessinger, D., Rudan, I., Hicks, A.A., Penninx, B.W., Thorand, B., Gieger, C., Coresh, J., Willemsen, G., Harris, T.B., Uitterlinden, A.G., Järvelin, M.R., Rice, K., Radke, D., Salomaa, V., Willems Van Dijk, K., Boerwinkle, E., Vasan, R.S., Ferrucci, L., Gibson, Q.D., Bandinelli, S., Snieder, H., Boomsma, D.I., Xiao, X., Campbell, H., Hayward, C., Pramstaller, P.P., Van Duijn, C.M., Peltonen, L., Psaty, B.M., Gudnason, V., Ridker, P.M., Homuth, G., Koenig, W., Ballantyne, C.M., Witteman, J.C.M., Benjamin, E.J., Perola, M., Chasman, D.I., 2011. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123, 731–738. 10.1161/CIRCULATIONAHA.110.948570. Diao, 2020, Statistically efficient association analysis of quantitative traits with haplotypes and untyped SNPs in family studies, BMC Genet., 21, 1, 10.1186/s12863-020-00902-x Dinarello, 2018, Overview of the IL-1 family in innate inflammation and acquired immunity, Immunol. Rev., 281, 8, 10.1111/imr.12621 Esmaeilzadeh, 2021, Immunobiological properties and clinical applications of interleukin-38 for immune-mediated disorders: A systematic review study, Int. J. Mol. Sci., 22, 12552, 10.3390/ijms222212552 Farh, 2015, Genetic and epigenetic fine mapping of causal autoimmune disease variants, Nature, 518, 337, 10.1038/nature13835 Gao, 2021, Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections, Cell Death Dis., 12, 1, 10.1038/s41419-020-03283-2 Han, 2021, The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases, Front. Pharmacol., 12, 2306, 10.3389/fphar.2021.732790 Herder, 2014, Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits, Diabetes, 63, 4343, 10.2337/db14-0731 Karaba, 2021, Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology, Clin. Infect. Dis. Kel, 2003, MATCHTM: A tool for searching transcription factor binding sites in DNA sequences, Nucleic Acids Res., 31, 3576, 10.1093/nar/gkg585 Lambert, 2018, The Human Transcription Factors, Cell, 172, 650, 10.1016/j.cell.2018.01.029 Li, 2020, Coronavirus disease 2019 (COVID-19): current status and future perspectives, Int. J. Antimicrob. Agents, 55, 10.1016/j.ijantimicag.2020.105951 Liu, 2008, Haplotype-Association Analysis, Adv. Genet., 60, 335, 10.1016/S0065-2660(07)00414-2 Mahmood, 2022, Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients, Meta Gene, 31, 10.1016/j.mgene.2022.101014 Mardi, 2021, Interleukin-1 in COVID-19 Infection: Immunopathogenesis and Possible Therapeutic Perspective, Viral Immunol., 34, 679, 10.1089/vim.2021.0071 Mozzi, 2018, Genetic susceptibility to infectious diseases: Current status and future perspectives from genome-wide approaches, Infect. Genet. Evol., 66, 286, 10.1016/j.meegid.2017.09.028 Notz, 2020, Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome—An Observational Pilot Study, Front. Immunol., 11, 2631, 10.3389/fimmu.2020.581338 Ovsyannikova, 2020, The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity, Immunol. Rev., 296, 205, 10.1111/imr.12897 Pal, 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update, Cureus, 12, e7423 Rabaan, 2021, Role of inflammatory cytokines in covid-19 patients: A review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm, Vaccines, 9, 436, 10.3390/vaccines9050436 Sayers, 2022, Database resources of the national center for biotechnology information, Nucleic Acids Res., 50, D20, 10.1093/nar/gkab1112 Shi, 2005, SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci, Cell Res., 15, 97, 10.1038/sj.cr.7290272 Singh, 2020, Promoter polymorphisms in IL-6 gene influence pro-inflammatory cytokines for the risk of osteoarthritis, Cytokine, 127, 10.1016/j.cyto.2020.154985 Soderquest, 2017, Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease, PLoS Genet., 13, e1006587, 10.1371/journal.pgen.1006587 Stock, C., 2011. The Interleukin 1 Gene Family in Systemic Juvenile Idiopathic Arthritis. University College London. Suh, 2022, A systematic review on papers that study on Single Nucleotide Polymorphism that affects coronavirus 2019 severity, BMC Infect. Dis., 22, 47, 10.1186/s12879-022-07034-w Tripathi, 2017, Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation, Cell Rep., 19, 1888, 10.1016/j.celrep.2017.05.013 Velavan, 2021, Host genetic factors determining COVID-19 susceptibility and severity, EBioMedicine, 72, 10.1016/j.ebiom.2021.103629 Vohra, 2021, SNPs in Sites for DNA Methylation, Transcription Factor Binding, and miRNA Targets Leading to Allele-Specific Gene Expression and Contributing to Complex Disease Risk: A Systematic Review, Public Health Genomics, 23, 155, 10.1159/000510253 Wong, 2022, Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?, Nat. Rev. Immunol., 22, 47, 10.1038/s41577-021-00656-2 World Health Organization, 2020. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance 28 January 2020. Who. Xia, H. song, Liu, Y., Fu, Y., Li, M., Wu, Y. qing, 2021. Biology of interleukin-38 and its role in chronic inflammatory diseases. Int. Immunopharmacol. 95, 107528. 10.1016/j.intimp.2021.107528. Xie, 2019, IL-38: A new player in inflammatory autoimmune disorders, Biomolecules, 9, 345, 10.3390/biom9080345